Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease.
about
Cellular interplay between neurons and glia: toward a comprehensive mechanism for excitotoxic neuronal loss in neurodegenerationThe Role of Oxidative Stress in Neurodegenerative DiseasesMicroglial cell dysregulation in brain aging and neurodegenerationOxidative Stress in Neurodegenerative DiseasesThe Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseasesViruses and neurodegenerationExpression and activities of aldo-keto oxidoreductases in Alzheimer diseaseGlutathione elevation by gamma-glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implication for chemobrainGlutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activityAmyloid-beta neuroprotection mediated by a targeted antioxidant.Cdk5 activity in the brain - multiple paths of regulation.Microarray analysis on human neuroblastoma cells exposed to aluminum, β(1-42)-amyloid or the β(1-42)-amyloid aluminum complex.Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer diseaseInvolvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.First evidence of overlaps between HIV-Associated Dementia (HAD) and non-viral neurodegenerative diseases: proteomic analysis of the frontal cortex from HIV+ patients with and without dementia.γ-Glutamylcysteine ameliorates oxidative injury in neurons and astrocytes in vitro and increases brain glutathione in vivo.Review on pharmacological activities of Cinnamomum iners Reinw. ex Blume.Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progressionMacrophage Migration Inhibitory Factor is subjected to glucose modification and oxidation in Alzheimer's Disease.Risk factors for Alzheimer's disease: role of multiple antioxidants, non-steroidal anti-inflammatory and cholinergic agents alone or in combination in prevention and treatment.Elucidating novel mechanisms of brain injury following subarachnoid hemorrhage: an emerging role for neuroproteomicsCharacterization of Aldh2 (-/-) mice as an age-related model of cognitive impairment and Alzheimer's diseaseMitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.Oxidative Stress and Its Clinical Applications in DementiaRole of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease.Glutathione S-transferases variants as risk factors in Alzheimer's disease.Neuronal and vascular oxidative stress in Alzheimer's disease.Interactions of glutathione transferases with 4-hydroxynonenal.Vascular oxidative stress in Alzheimer diseaseAlterations in Lipid Levels of Mitochondrial Membranes Induced by Amyloid-β: A Protective Role of Melatonin.Gene-environment interplay in neurogenesis and neurodegeneration.Antioxidative and steroid systems in neurological and psychiatric disorders.Effects of APOE rs429358, rs7412 and GSTM1/GSTT1 Polymorphism on Plasma and Erythrocyte Antioxidant Parameters and Cognition in Old Chinese Adults.Role of ABC transporters in the pathogenesis of Alzheimer's diseaseExpression of Nrf2 in neurodegenerative diseasesNrf2--a therapeutic target for the treatment of neurodegenerative diseases.Roles of glutathione in antioxidant defense, inflammation, and neuron differentiation in the thalamus of HIV-1 transgenic rats.Impaired glutathione synthesis in neurodegeneration.Proteomic Analysis of Mitochondria-Enriched Fraction Isolated from the Frontal Cortex and Hippocampus of Apolipoprotein E Knockout Mice Treated with Alda-1, an Activator of Mitochondrial Aldehyde Dehydrogenase (ALDH2)Redox proteomics studies of in vivo amyloid beta-peptide animal models of Alzheimer's disease: Insight into the role of oxidative stress.
P2860
Q24654460-10C6AB61-EB12-421B-8D83-100B3E782F37Q26771758-EA5C575C-7EE3-4C24-940F-A41F8337C9BDQ26800212-C03B94C2-E54A-4B97-A428-ABF9E14B8593Q26801239-F7540941-48E9-40E1-93BA-8527FF08C168Q26822972-67F9624C-FB6D-4E09-BB2E-568EB837FE2CQ26991740-45D5D9BD-21E6-42B2-A2EA-5260F0EA5169Q28205423-1D0B87A9-F36C-49D1-854E-C5F30FE8E681Q28279190-DE295AC4-E328-4048-B02A-D2E8AC693771Q28565510-A3D4BC4A-E883-4AA6-A4F2-8EB965990B4AQ33612650-9EDDDA45-88D1-4275-B771-6FE3D7B90B2DQ33687591-DB9C91C5-B45D-499E-84FD-F17844E2543BQ33813237-83E4B21C-D9A8-479E-B15C-4CC817DAA975Q33897525-489B58F7-05F0-4444-9454-66A9271E79ACQ33915362-A7D53322-69B6-4B3D-86CB-CA3EBCC91512Q33995872-D2A52823-D15A-4A15-9712-1E21DD713714Q34155019-A6C4B038-912D-49B2-A616-110941BE56AFQ34265175-4F8BCA90-8DB2-438E-AA74-132563704784Q34512386-FE47F985-F037-4BB1-98C9-8BA6EFCD5484Q34551906-AD7AD0BA-C1A4-4968-8EB2-B9438F339FBFQ35025023-EC00140A-93FC-4827-AC8B-587659579DE0Q35152170-F88166C1-C06B-4B59-B0C9-A143E4281EE0Q35537887-6601B648-5B1C-4121-8827-E5D14485BE17Q35540388-7747877D-BBF2-4ED8-B1FD-45FEE504F414Q35623258-5AD16CD2-33C9-45B2-9499-321DD1B65B71Q35625434-13189B0E-F07C-4786-810B-70392B7A0012Q35633545-B76F7F22-91F1-4EA4-8A7D-7CA11DBD8701Q35687039-A650E594-826F-4195-8994-46EB821E4E49Q35731685-CD453685-9D9D-4B26-A13D-585BB7148621Q35951646-F9764F5C-15BB-4D84-95F1-F1090115F192Q35993891-B234C0D5-903A-4019-8D59-30FF43EC5F7BQ36003798-68919528-67D9-42E5-BDC6-07B0A3ED7881Q36227621-4E2E718A-892A-466B-84D0-B32DBC0FBF22Q36246699-417F66EF-8C21-4131-838A-3447D0C7CF53Q36418108-7543DCE0-BE9B-4123-A120-9021D270B923Q36477584-7675B6F1-564A-45B3-8E82-7283F76FAFCEQ36732766-D68C4B91-E041-4D66-A2A4-22ECA82794D0Q36904688-74E69A14-C75D-47DC-A701-7B834DDA87CDQ37291406-FACA9D6F-6A75-460B-8B71-B86E1A5301ECQ37691024-25064F5F-BDCA-418C-8D68-2F4C92B06944Q37817235-F23BBBB5-BB78-4D21-A668-6896F5E5ADA8
P2860
Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Decreased glutathione transfer ...... fluid in Alzheimer's disease.
@en
Decreased glutathione transfer ...... fluid in Alzheimer's disease.
@nl
type
label
Decreased glutathione transfer ...... fluid in Alzheimer's disease.
@en
Decreased glutathione transfer ...... fluid in Alzheimer's disease.
@nl
prefLabel
Decreased glutathione transfer ...... fluid in Alzheimer's disease.
@en
Decreased glutathione transfer ...... fluid in Alzheimer's disease.
@nl
P2093
P356
P1433
P1476
Decreased glutathione transfer ...... fluid in Alzheimer's disease.
@en
P2093
P304
P356
10.1212/WNL.51.6.1562
P407
P577
1998-12-01T00:00:00Z